ACUSON Sequoia Select Diagnostic Ultrasound System vs Tempus ECG-AF
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 60/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
Tool A is an AI-powered ultrasound system designed for comprehensive diagnostic imaging across various specialties, including cardiology, focusing on enhanced image quality and workflow. Tool B is an AI-based software algorithm specifically for analyzing ECGs to identify the risk of new-onset atrial fibrillation in older patients. While both utilize AI in cardiology, they address different diagnostic needs and employ distinct modalities, making them complementary rather than direct competitors.
Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Frequently Asked Questions
The ACUSON Sequoia Select Diagnostic Ultrasound System is an advanced ultrasound platform for general diagnostic imaging across diverse clinical applications, including cardiology, OB/GYN, and radiology. Tempus ECG-AF is an AI-based algorithm designed to analyze 12-lead ECG recordings to identify patients aged 65 or older at increased risk of developing atrial fibrillation/flutter within the next 12 months.
The ACUSON Sequoia Select utilizes BioAcousticu2122 imaging technology, InFocus Imaging, and InTune Transducer Technology to deliver exceptional ultrasound image quality and penetration. Tempus ECG-AF employs an AI-based algorithm trained on over 1.5 million ECGs to analyze 12-lead ECG data for AF risk detection.
The ACUSON Sequoia Select is designed for diverse patient populations and clinical applications in cardiology, gastroenterology, and radiology. Tempus ECG-AF is specifically intended for patients aged 65 or older without pre-existing AF, pacemakers, ICDs, or recent cardiac surgery, to assess their risk of new-onset AF.
Pricing for the ACUSON Sequoia Select is not publicly disclosed, and reimbursement details are not provided. For Tempus ECG-AF, CMS reimbursement is available using CPT codes 0764T and 0765T, assigned to APC 5734, with a Medicare rate of $128.90, effective January 1, 2025.
The ACUSON Sequoia Select features AI-powered automatic image parameter settings with UltraArt and smart automation to optimize workflow. Tempus ECG-AF uses an AI-based algorithm to analyze 12-lead ECG recordings to detect signs associated with new-onset Atrial Fibrillation within 12 months.